Please login to the form below

Not currently logged in
Email:
Password:

GS-5806

This page shows the latest GS-5806 news and features for those working in and with pharma, biotech and healthcare.

Gilead's RSV drug clears mid-stage trial

Gilead's RSV drug clears mid-stage trial

Gilead's RSV drug clears mid-stage trial. Late-stage data demonstrates GS-5806 is effective in treating the infection. ... The company presented the results of a study of GS-5806, an orally-active RSV fusion inhibitor, showing that it was able to limit

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics